Immix Biopharma (IMMX) EBITDA (2021 - 2026)
Quarterly results put EBITDA at -$10.0 million for Q1 2026, down 121.86% from a year ago — trailing twelve months through Mar 2026 was -$34.9 million (down 66.38% YoY), and the annual figure for FY2025 was -$29.4 million, down 35.07%.
Immix Biopharma has reported EBITDA over the past 6 years, most recently at -$10.0 million for Q1 2026.
- EBITDA reached -$10.0 million in Q1 2026 per IMMX's latest filing, up from -$10.7 million in the prior quarter.
- Across five years, EBITDA topped out at -$1.3 million in Q1 2022 and bottomed at -$10.7 million in Q4 2025.
- Median EBITDA over the past 5 years was -$4.5 million (2025), compared with a mean of -$5.0 million.
- Peak annual rise in EBITDA hit 83.41% in 2022, while the deepest fall reached 685.2% in 2022.
- Over 5 years, EBITDA stood at -$3.8 million in 2022, then crashed by 32.5% to -$5.0 million in 2023, then dropped by 0.07% to -$5.0 million in 2024, then tumbled by 113.58% to -$10.7 million in 2025, then grew by 6.07% to -$10.0 million in 2026.
- Business Quant data shows EBITDA for IMMX at -$10.0 million in Q1 2026, -$10.7 million in Q4 2025, and -$7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 661.60 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -10.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.04 Mn |
| Dec 31, 2025 | -10.69 Mn |
| Sep 30, 2025 | -7.59 Mn |
| Jun 30, 2025 | -6.57 Mn |
| Mar 31, 2025 | -4.53 Mn |
| Dec 31, 2024 | -5.01 Mn |
| Sep 30, 2024 | -7.07 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Mar 31, 2024 | -5.30 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -4.31 Mn |
| Jun 30, 2023 | -3.58 Mn |
| Mar 31, 2023 | -2.48 Mn |
| Dec 31, 2022 | -3.77 Mn |
| Sep 30, 2022 | -1.58 Mn |
| Jun 30, 2022 | -1.60 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | -22.75 Mn |
| Sep 30, 2021 | -406,784.00 |
| Jun 30, 2021 | -203,940.00 |
| Mar 31, 2021 | -1.03 Mn |